Patient reported outcomes for cancer patients receiving immunotherapy: opportunities for palliative care – A Systematic Review

Immune checkpoint inhibitors (ICIs) are increasingly used to treat a variety of cancers, but comparatively little is known about patient-reported outcomes (PROs) and health-related quality of life (HRQoL) among patients receiving these novel therapies.

Source: Journal of Pain and Symptom Management - March 20, 2019 Category: Palliative Care Authors: Evan T. Hall, Surbhi Singhal, James Dickerson, Brooke Gabster, Hong-nei Wong, Rebecca A. Aslakson, Lidia Schapira Source Type: research